Skip to main content

Day: September 28, 2023

Global Tetrahydrofuran (THF) Market Size to Reach USD 8.33 Billion in 2032 | Emergen Research

Rising demand for spandex fiber is one of the major factors driving market revenue growth Vancouver, Sept. 28, 2023 (GLOBE NEWSWIRE) — The global Tetrahydrofuran (THF) market size was USD 4.21 Billion in 2022 and is expected to register a revenue CAGR of 7.1% during the forecast period to the latest analysis by Emergen Research. Rising demand for spandex fiber is driving the market revenue growth. Tetrahydrofuran (THF) demand rise in the automotive and transportation sectors is expected to drive revenue growth of the market. The automotive and transportation sectors control a large portion of the Tetrahydrofuran (THF) market. To meet regulatory requirements and improve vehicle fuel efficiency, automakers are focusing on manufacturing lightweight cars made of composite materials to reduce Carbon Dioxide (CO2) emissions, which have...

Continue reading

Innofactor Plc: Share Repurchase 28.9.2023

Innofactor Plc Announcement 28.9.2023          Innofactor Plc: Share Repurchase 28.9.2023       In the Helsinki Stock Exchange         Trade date 28.9.2023  Bourse trade Buy  Share IFA1V  Amount 6,300 SharesAverage price/ share 1.1150 EURTotal cost 7,024.50 EUR          Innofactor Plc now holds a total of 243 256 sharesincluding the shares repurchased on 28.9.2023            On behalf of Innofactor Plc         Nordea Bank Oyj         Janne Sarvikivi Sami Huttunen       Additional information:    Sami Ensio, CEO    Innofactor Plc    Tel. +358 50 584 2029    sami.ensio@innofactor.com         www.innofactor.com       AttachmentInnofactor_28.9_trades

Continue reading

Home Plate Acquisition Corporation Announces Adjournment of Special Meeting of Stockholders Until 11:00 AM Eastern Time On October 2, 2023

NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) — Home Plate Acquisition Corporation (the “Company” or “Home Plate”) (NASDAQ: HPLT) announced that it convened and then adjourned, without conducting any business, its special meeting of stockholders (the “Special Meeting”). The Special Meeting has been adjourned to 11:00 a.m., Eastern Time, on October 2, 2023, as a virtual meeting at www.virtualshareholdermeeting.com/HPLT2023SM2. The Special Meeting is being held for the purposes of considering and voting on (i) the Extension Amendment Proposal, (ii) the Trust Amendment Proposal and (iii) the Redemption Limitation Amendment Proposal, each as described in Home Plate’s definitive proxy statement filed with the Securities and Exchange Commission (“SEC”) on September 18, 2023. The proxy card included with the previously distributed proxy materials...

Continue reading

Bocana Resources Corp. Completes Approximately 500 metres of Diamond Drill Testing at the Escala Project in Bolivia

CALGARY, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) — Bocana Resources Corp. (TSXV: BOCA) (Frankfurt: VC1) (“Bocana” or the “Company“) is pleased to announce the completion of the first two of nine proposed diamond drill holes on the Escala area concession in south-west Bolivia. The Company’s inaugural drilling of both NQ and HQ size cores is expected to take another three weeks to complete the proposed 2,000 metre program. Lithologies Observed The two completed holes tested the southern flank of a large, induced polarization chargeability anomaly that is interpolated to be related to a mineralized near surface porphyry system called Cerro Galapagos. Hydrothermal and intrusion breccias hosted within a dacitic porphyry have been observed. Fracture controlled sulphides, mainly pyrite and minor arsenopyrites...

Continue reading

Synlogic Announces Publication of Synpheny-1 Phase 2 Study of Synthetic Biotic for Phenylketonuria in Nature Metabolism

CAMBRIDGE, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) — Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, today announced the publication of results from its Synpheny-1 Phase 2 study of its drug candidates, labafenogene marselecobac (SYNB1934) and SYNB1618 in patients with phenylketonuria (PKU) in the journal Nature Metabolism. The publication, entitled “Efficacy and Safety of a Synthetic Biotic for Treatment of Phenylketonuria: a Phase 2 Clinical Trial” is now available online at https://www.nature.com/articles/s42255-023-00897-6. The paper includes a comprehensive review of the data, showing clinically meaningful, dose-dependent reductions in plasma phenylalanine (Phe). “These positive results build on a...

Continue reading

Stephen C. VanSuch Joins Stifel to Lead Youngstown Market

Veteran Financial Advisor and Manager Was Responsible for $500 Million in Client Assets at Merrill ST. LOUIS, Sept. 28, 2023 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today announced that Stephen C. VanSuch has joined the firm’s Stifel, Nicolaus & Company, Incorporated broker-dealer subsidiary as Managing Director/Investments and Branch Manager in Canfield, Ohio. In this role, he will work with Ralph Fajack, Branch Manager, to lead the Youngstown market. Mr. VanSuch comes to Stifel after spending 24 years as a Managing Director at Merrill Lynch, where he was responsible for approximately $500 million in client assets and previously served as a Senior Resident Director.   Stifel’s history in the Mahoning Valley region dates back decades, furthered by its 2008 acquisition of Youngstown-based Butler Wick & Company,...

Continue reading

Erayak Power Solution Group Inc. In Discussions with Potential Strategic Partners to Expand Market Opportunities and Product Offerings

Wenzhou, China, Sept. 28, 2023 (GLOBE NEWSWIRE) — Erayak Power Solution Group Inc. (“Erayak” or the “Company”) (Nasdaq: RAYA), a leading manufacturer, designer, and exporter of high-quality products in the power supply industry, is pleased to announce that the Company is discussing with potential strategic partners to expand its market opportunities and product reach. One of the potential partners is a diversified energy company that produces and markets fuels, natural gases, and electricity. The company has been established in China for nearly 40 years and is actively involved in the entire Chinese energy industry supply chain, from both upstream to downstream operations. Erayak is looking to share experience, technology, and industry expertise to create mutually beneficial partnerships to develop domestic...

Continue reading

Toll Brothers Opens New Waterfront Community in St. Johns, Florida

Shores at Rivertown offers single-family homes and waterfront townhomes with access to optional boat slips and within walking distance of master-planned amenitiesToll Brothers Shores at RiverTownToll Brothers’ new waterfront community, Shores at RiverTown, is now open with single-family homes and waterfront townhomes in St. Johns, FloridaToll Brothers Shores at RiverTown“We are excited to bring our luxury home designs to this well-known master-planned community where family and lifestyle remain key for our home buyers,” said Greg Netro, Group President of Toll Brothers in North Florida.Toll Brothers Shores at RiverTownShores at RiverTown will offer Toll Brothers single-family homes ranging from 1,607 to 3,000+ square feet and low-maintenance, waterfront townhomes from 2,041 to 2,394+ square feet.JACKSONVILLE,...

Continue reading

Global Phase Transfer Catalyst (PTC) Market Size to Reach USD 2037.7 Million in 2032 | Emergen Research

Increasing adoption of green chemistry in organic synthesis is one of the key factors driving market revenue growth Vancouver, Sept. 28, 2023 (GLOBE NEWSWIRE) — The global Phase Transfer Catalyst (PTC) market size was USD 1,217.6 Million in 2022 and is expected to register a steady revenue CAGR of 5.3% during the forecast period, according to the latest analysis by Emergen Research. Increasing adoption for green chemistry in organic synthesis is a key factors driving market revenue growth. A PTC is a type of heterogeneous catalysis that allows a reactant to migrate from one phase to another while the reaction is taking place. This catalyst acts as a detergent, allowing salts to be dissolved into the organic phase. PTC catalyst products are widely used by the healthcare sector for a range of processes, including production of pharmaceutical...

Continue reading

Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facility and the Associated $400 Million 10-Year Purchase Agreement with Nephron Pharmaceuticals

Transformative acquisition and purchase order enables Sharps to commercialize its innovative copolymer prefillable syringe systems to the healthcare market Company has a capitalization strategy through debt that has resulted in a signed term sheet with a leading middle-market lender for up to $75 Million NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, issues a shareholder update from Robert Hayes, the Company’s Chief Executive Officer. Dear Fellow Shareholders: I am pleased to update you on Sharps’ recently signed Asset Purchase Agreement to acquire the InjectEZ facility, a specialty prefillable syringe manufacturing facility, and the associated $400 Million...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.